Amended Report of Foreign Issuer (6-k/a)
November 28 2017 - 4:32PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
Form 6-K/A
(Amendment
No. 1)
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16 UNDER
THE
SECURITIES EXCHANGE ACT OF 1934
For
the month of November 2017
Commission
File Number 001-37846
CELLECT
BIOTECHNOLOGY LTD.
(Translation
of registrant’s name into English)
23
Hata’as Street
Kfar
Saba, Israel 44425
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(1): ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(7): ☐
Explanatory
Note
On
November 7, 2017, Cellect Biotechnology Ltd. (the “Company”) furnished a Form 6-K (the “Original Report”)
attaching a Notice and Proxy Statement, form of Proxy Card and Voting Instruction Card for an Extraordinary General Meeting of
Shareholders. The Company has made certain changes to the Notice and Proxy Statement including the vesting provisions of
Proposal 3. Attached to this Amended Report on Form 6-K/A is the updated Notice and Proxy Statement that is being sent to
shareholders of the Company. There are no other changes to the Original Report other than as reflected in this Amended Report.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
Cellect Biotechnology Ltd.
|
|
|
|
Date: November 28, 2017
|
By:
|
/s/
Eyal Leibovitz
|
|
|
Name: Eyal Leibovitz
|
|
|
Title: Chief Financial Officer
|
3
Cellect Biotechnology (NASDAQ:APOP)
Historical Stock Chart
From Jul 2024 to Aug 2024
Cellect Biotechnology (NASDAQ:APOP)
Historical Stock Chart
From Aug 2023 to Aug 2024